Chordia Therapeutics Inc. (TYO:190A)
43.00
0.00 (0.00%)
Nov 18, 2026, 10:56 AM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 3.33 billion as of November 17, 2026. It is the 36,314th most valuable company in the world and the 3,341st biggest in Japan. Its market cap has decreased by 54.94% in one year.
Market Cap
3.33B
Enterprise Value
1.27B
Revenue
n/a
Global Rank
Country Rank
#3,341 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 3.33B, a decrease of -73.57%. That is a compound annual growth rate of -42.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.33B | -55.35% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 4.84B |
| Kringle Pharma | 4.67B |
| SUSMED,Inc. | 4.24B |
| PRISM BioLab Co.,LTD | 3.96B |
| Noile-Immune Biotech | 3.73B |
| Modalis Therapeutics | 3.41B |
| Kohjin Bio | 3.39B |
| Transgenic Group | 3.38B |